Citi Downgrades Hospira (HSP) to Sell
Tweet
Share
E-mail
Get Alerts HSP Hot Sheet
Price: $89.95 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Citi downgraded Hospira (NYSE: HSP) from Hold to Sell. PT increased from $52 to $54.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
Shares of Hospira closed at $57.35 yesterday.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
Shares of Hospira closed at $57.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- Barclays Downgrades ACV Auctions Inc (ACVA) to Underweight
- Northcoast Downgrades MarineMax (HZO) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
